Clinical Trial Update: Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis [Phase 4]

View source ↗

Summary

Phase 4 trial defining optimal duration for low-risk peritoneal dialysis-related peritonitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Dialysis-associated Peritonitis

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Peritoneal Dialysis-associated Peritonitis | Phase 4 | Status: WITHDRAWN